Page last updated: 2024-09-03

mozavaptan and Hyponatremia

mozavaptan has been researched along with Hyponatremia in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (50.00)18.2507
2000's7 (35.00)29.6817
2010's3 (15.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwao, H; Izumi, Y; Miura, K1
Villabona, C1
Dabrowska, MD; Krysiak, R; Okopień, B1
Shimizu, K1
Arata, T; Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sasaki, S; Sato, A; Satomi, S; Suzuki, K; Suzuki, M1
Ishikawa, SE; Sasaki, M1
Arata, T; Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sanada, S; Sasaki, S; Sato, A; Satomi, S; Suzuki, M1
Gross, P; Herbrig, K; Palm, C; Pistrosch, F1
Ginès, P; Guevara, M; Martín-Llahí, M1
Fujisawa, G; Ishikawa, S; Okada, K; Saito, T; Tsuboi, Y2
Saito, T1
Abe, K; Ishikawa, S; Kamoi, K; Saito, T; Saruta, T; Shimizu, K; Yamada, K; Yoshida, S1
Kamoi, K1
Buchfelder, M; Gross, P; Hensen, J1
Kitiyakara, C; Wilcox, CS1
Ishikawa, S; Saito, T2
Nakahama, H; Orita, Y1
Gross, P; Palm, C1

Reviews

11 review(s) available for mozavaptan and Hyponatremia

ArticleYear
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
    Journal of pharmacological sciences, 2014, Volume: 124, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling

2014
[Vasopressin receptor antagonists: the vaptans].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins

2010
[Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2012, Volume: 65, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzamides; Benzazepines; Diuretics; Heart Failure; Humans; Hyponatremia; Hypovolemia; Morpholines; Pyrroles; Spiro Compounds; Tolvaptan

2012
[Renal action of vasopressin].
    Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64 Suppl 2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Diabetes Insipidus; Diabetes Insipidus, Nephrogenic; Drug Design; Humans; Hyponatremia; Inappropriate ADH Syndrome; Mutation; Piperidines; Quinolones; Receptors, Vasopressin

2006
Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    The American journal of medicine, 2006, Volume: 119, Issue:7 Suppl 1

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Morpholines; Pyrroles; Randomized Controlled Trials as Topic; Spiro Compounds; Tolvaptan; Vasopressins

2006
Hyponatremia in cirrhosis: clinical features and management.
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:10

    Topics: Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Brain; Clinical Trials, Phase II as Topic; Controlled Clinical Trials as Topic; Creatinine; Forecasting; Hepatic Encephalopathy; Humans; Hyponatremia; Liver Cirrhosis; Liver Transplantation; Prognosis; Research; Risk Factors; Sodium; Time Factors; Treatment Outcome

2006
SIADH and other hyponatremic disorders: diagnosis and therapeutic problems.
    Nihon Jinzo Gakkai shi, 1996, Volume: 38, Issue:10

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diagnosis, Differential; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kallikreins; Uric Acid

1996
Vasopressin V2-receptor antagonists: panaceas for hyponatremia?
    Current opinion in nephrology and hypertension, 1997, Volume: 6, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Humans; Hyponatremia; Morpholines; Receptors, Vasopressin; Spiro Compounds

1997
[Disorders of body water regulation and the therapy--vasopressin antagonists].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Sep-10, Volume: 86, Issue:9

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines

1997
[Disorders of body water regulation and the therapy using diuretics].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1997, Sep-10, Volume: 86, Issue:9

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Benzothiadiazines; Diuretics; Edema; Humans; Hyponatremia; Sodium Chloride Symporter Inhibitors; Sulfonamides

1997
The treatment of hyponatraemia using vasopressin antagonists.
    Experimental physiology, 2000, Volume: 85 Spec No

    Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Vasopressins

2000

Trials

2 trial(s) available for mozavaptan and Hyponatremia

ArticleYear
Combined effects of vasopressin V2 receptor antagonist and loop diuretic in humans.
    Clinical nephrology, 2003, Volume: 59, Issue:3

    Topics: Adult; Benzazepines; Cross-Over Studies; Diuretics; Drug Therapy, Combination; Edema; Electrolytes; Furosemide; Hemodynamics; Humans; Hyponatremia; Male; Osmolar Concentration; Potassium; Regression Analysis; Renin; Sodium; Urination; Water

2003
Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:4

    Topics: Aged; Arginine Vasopressin; Benzazepines; Diuresis; Diuretics; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Osmolar Concentration; Sodium; Treatment Outcome; Urine

1997

Other Studies

7 other study(ies) available for mozavaptan and Hyponatremia

ArticleYear
BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
    Kidney international, 2005, Volume: 67, Issue:5

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Aquaporins; Benzazepines; Deamino Arginine Vasopressin; Diuretics; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Kidney Medulla; Male; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Urea; Water

2005
Lithium effectively complements vasopressin V2 receptor antagonist in the treatment of hyponatraemia of SIADH rats.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:1

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzazepines; Diabetes Insipidus, Nephrogenic; Disease Models, Animal; Drug Synergism; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Lithium Chloride; Male; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin

2007
Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats.
    Kidney international, 1993, Volume: 44, Issue:1

    Topics: Animals; Benzazepines; Deamino Arginine Vasopressin; Hyponatremia; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Sodium; Vasopressins

1993
Nonpeptide vasopressin antagonist and its application in the correction of experimental hyponatremia in rats.
    Regulatory peptides, 1993, Apr-29, Volume: 45, Issue:1-2

    Topics: Animals; Benzazepines; Cells, Cultured; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Muscle, Smooth, Vascular; Piperidines; Quinolones; Rats; Rats, Brattleboro; Rats, Sprague-Dawley; Vasopressins

1993
Syndrome of inappropriate antidiuresis without involving inappropriate secretion of vasopressin in an elderly woman: effect of intravenous administration of the nonpeptide vasopressin V2 receptor antagonist OPC-31260.
    Nephron, 1997, Volume: 76, Issue:1

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Injections, Intravenous; Sodium; Vasopressins

1997
[Aquaretic drugs--a new therapeutic principle in treatment of hyponatremia?].
    Fortschritte der Medizin, 1997, Jun-20, Volume: 115, Issue:17

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Male; Vasopressins

1997
Therapeutic efficacy of vasopressin receptor antagonists.
    Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:2

    Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuresis; Edema; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Rats

1998